Fowler Bruce A, Conner Elizabeth A, Yamauchi Hiroshi
Program in Toxicology, University of Maryland, Baltimore, MD 21201, USA.
Toxicol Appl Pharmacol. 2005 Aug 7;206(2):121-30. doi: 10.1016/j.taap.2005.01.020.
A pressing need exists to develop and validate molecular biomarkers to assess the early effects of chemical agents, both individually and in mixtures. This is particularly true for new and chemically intensive industries such as the semiconductor industry. Previous studies from this laboratory and others have demonstrated element-specific alterations of the heme biosynthetic pathway for the III-V semiconductors gallium arsenide (GaAs) and indium arsenide (InAs) with attendant increased urinary excretion of specific heme precursors. These data represent an example of a metabolomic biomarker to assess chemical effects early, before clinical disease develops. Previous studies have demonstrated that the intratracheal or subcutaneous administration of GaAs and InAs particles to hamsters produces the induction of the major stress protein gene families in renal proximal tubule cells. This was monitored by 35-S methionine labeling of gene products followed by two-dimensional gel electrophoresis after exposure to InAs particles. The present studies examined whether these effects were associated with the development of compound-specific proteinuria after 10 or 30 days following subcutaneous injection of GaAs or InAs particles in hamsters. The results of these studies demonstrated the development of GaAs- and InAs-specific alterations in renal tubule cell protein expression patterns that varied at 10 and 30 days. At the 30-day point, cells in hamsters that received InAs particles showed marked attenuation of protein expression, suggesting inhibition of the stress protein response. These changes were associated with GaAs and InAs proteinuria patterns as monitored by two-dimensional gel electrophoresis and silver staining. The intensity of the protein excretion patterns increased between the 10- and 30-day points and was most pronounced for animals in the 30-day InAs treatment group. No overt morphologic signs of cell death were seen in renal tubule cells of these animals. Western blot analyses of the urines with antibodies to the 32-, 70-, and 90-kDa stress protein families did not show the presence of these molecules, indicating that these proteins were not excreted in the urine samples. These data suggest that the observed proteinuria patterns were not a result of cell death and that the observed chemical-specific proteinurias were produced before marked cellular toxicity. These findings suggest a hypothesis involving GaAs and InAs interference with stress protein chaperoning of reabsorbed proteins for proteosomic degradation and the probable chaperoning of damaged intracellular proteins from renal proximal tubule cells into the urinary filtrate. Overall, the results of these studies provide further information on the nephrotoxicity of these semiconductor compounds. They also suggest the use of two-dimensional gel electrophoresis with silver staining of urinary protein patterns as a potentially useful proteomic approach to renal damage early in relation to intracellular proteotoxicity in kidney tubule cells.
迫切需要开发和验证分子生物标志物,以评估化学物质单独或混合使用时的早期影响。对于半导体行业等新兴的化学密集型产业来说尤其如此。本实验室和其他机构之前的研究表明,III-V族半导体砷化镓(GaAs)和砷化铟(InAs)会导致血红素生物合成途径发生元素特异性改变,同时特定血红素前体的尿排泄量增加。这些数据代表了一种代谢组学生物标志物的例子,可在临床疾病发生之前早期评估化学物质的影响。之前的研究表明,对仓鼠气管内或皮下注射GaAs和InAs颗粒会诱导肾近端小管细胞中主要应激蛋白基因家族的表达。这通过在暴露于InAs颗粒后用35-S甲硫氨酸标记基因产物,然后进行二维凝胶电泳来监测。本研究检查了在仓鼠皮下注射GaAs或InAs颗粒10天或30天后,这些影响是否与化合物特异性蛋白尿的发生有关。这些研究结果表明,在10天和30天时,肾小管细胞蛋白质表达模式出现了GaAs和InAs特异性改变。在30天这个时间点,接受InAs颗粒的仓鼠细胞显示出蛋白质表达明显减弱,表明应激蛋白反应受到抑制。通过二维凝胶电泳和银染监测,这些变化与GaAs和InAs蛋白尿模式相关。蛋白质排泄模式的强度在10天到30天之间增加,在30天InAs处理组的动物中最为明显。在这些动物的肾小管细胞中未观察到明显的细胞死亡形态学迹象。用针对32 kDa、70 kDa和90 kDa应激蛋白家族的抗体对尿液进行蛋白质印迹分析,未显示这些分子的存在,表明这些蛋白质未在尿液样本中排泄。这些数据表明,观察到的蛋白尿模式不是细胞死亡的结果,并且观察到的化学物质特异性蛋白尿是在明显的细胞毒性之前产生的。这些发现提出了一个假设,即GaAs和InAs干扰了用于蛋白质组降解的重吸收蛋白的应激蛋白伴侣作用,以及可能将受损的细胞内蛋白从肾近端小管细胞伴侣转运到尿液滤液中。总体而言,这些研究结果提供了关于这些半导体化合物肾毒性的进一步信息。它们还表明,二维凝胶电泳结合尿液蛋白质模式银染作为一种潜在有用的蛋白质组学方法,可用于早期检测与肾小管细胞内蛋白质毒性相关的肾损伤。